Trials / Sponsors / IDRX, Inc., a wholly owned subsidiary of GSK, LLC
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal T Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Digestive System Disease | Phase 1 | 2022-08-03 |